Clinical Trials Browser

Recurrence × cabozantinib × Gastrointestinal × Clear all

NCT04204850 2025-12-03

Cabozantinib to Treat Recurrent Liver Cancer Post Transplant

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Recurrence